Director/PDMR Shareholding
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1 | Details of the person discharging managerial responsibilities / person closely associated | ||
b) | Legal person | Private Assets (Asset Management) | |
2 | Reason for the notification | ||
a) | Position/status | Notification concerns PCA with the PDMRs: Member of the Board of Directors, President of PJSC "LUKOIL" Vagit Alekperov, Member of the Board of Directors, Vice President of PJSC "LUKOIL" Leonid Fedun | |
b) | Initial notification/Amendment | Initial notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Public Joint-Stock Company "LUKOIL" | |
b) | LEI | 549300LCJ1UJXHYBWI24 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; | ||
4.1 | |||
a) | Description of the financial instrument, type of instrument | PJSC "LUKOIL" ordinary shares | |
Identification code | RU0009024277 | ||
b) | Nature of the transaction | Purchase of PJSC "LUKOIL" ordinary shares | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
5835 | 1143 | ||
5837 | 857 | ||
5846.50 | 1000 | ||
5849.50 | 1000 | ||
5853 | 1000 | ||
5857.50 | 1000 | ||
5863 | 1000 | ||
5867 | 1000 | ||
5871 | 1000 | ||
5875 | 250 | ||
5933 | 518 | ||
5935 | 2000 | ||
5938 | 1000 | ||
5939.50 | 145 | ||
5940 | 337 | ||
5945 | 3000 | ||
5950 | 750 | ||
5955 | 2000 | ||
5959.50 | 1000 | ||
d) | Aggregated information | ||
Price | RUB 5902.963 | ||
Volume | 20,000 | ||
Total | RUB118,059,265.50 | ||
e) | Date of the transaction | 2019-10-23 | |
f) | Place of the transaction | Moscow Exchange (MISX) |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.